Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution.
Hematology Department and Transplant Centre, Armando Businco Cancer Centre, Via Edward Jenner, Cagliari, Italy. claromani@tiscali.it
C
C
Romani
M
M
Pettinau
R
R
Murru
E
E
Angelucci
D000293:Adolescent; D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine